Egypt: Medicaments Containing Hormones Market 2024

Medicaments Containing Hormones Market Size in Egypt

The Egyptian medicaments containing hormones market stood at $X in 2022, stabilizing at the previous year. Over the period under review, consumption posted buoyant growth. Over the period under review, the market hit record highs at $X in 2020; however, from 2021 to 2022, consumption failed to regain momentum.

Medicaments Containing Hormones Production in Egypt

In value terms, medicaments containing hormones production reached $X in 2022 estimated in export price. Over the period under review, production posted a buoyant increase. The pace of growth appeared the most rapid in 2015 when the production volume increased by X% against the previous year. Over the period under review, production hit record highs at $X in 2020; however, from 2021 to 2022, production remained at a lower figure.

Medicaments Containing Hormones Exports

Exports from Egypt

In 2022, overseas shipments of medicaments containing hormones but not antibiotics were finally on the rise to reach X tons after two years of decline. Overall, exports, however, continue to indicate a deep setback. The most prominent rate of growth was recorded in 2016 with an increase of X% against the previous year. As a result, the exports attained the peak of X tons. From 2017 to 2022, the growth of the exports remained at a lower figure.

In value terms, medicaments containing hormones exports skyrocketed to $X in 2022. In general, exports, however, faced a deep downturn. The exports peaked at $X in 2013; however, from 2014 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

Libya (X tons) was the main destination for medicaments containing hormones exports from Egypt, accounting for a X% share of total exports. Moreover, medicaments containing hormones exports to Libya exceeded the volume sent to the second major destination, Sudan (X tons), fourfold. The third position in this ranking was held by Syrian Arab Republic (X kg), with a X% share.

From 2012 to 2022, the average annual growth rate of volume to Libya stood at X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Sudan (X% per year) and Syrian Arab Republic (X% per year).

In value terms, Libya ($X) emerged as the key foreign market for medicaments containing hormones but not antibiotics exports from Egypt, comprising X% of total exports. The second position in the ranking was held by Syrian Arab Republic ($X), with a X% share of total exports. It was followed by Sudan, with an X% share.

From 2012 to 2022, the average annual growth rate of value to Libya amounted to X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Syrian Arab Republic (X% per year) and Sudan (X% per year).

Export Prices by Country

The average medicaments containing hormones export price stood at $X per ton in 2022, which is down by X% against the previous year. Overall, the export price continues to indicate a perceptible shrinkage. The most prominent rate of growth was recorded in 2021 when the average export price increased by X%. Over the period under review, the average export prices attained the maximum at $X per ton in 2015; however, from 2016 to 2022, the export prices failed to regain momentum.

There were significant differences in the average prices for the major external markets. In 2022, amid the top suppliers, the country with the highest price was Saudi Arabia ($X per ton), while the average price for exports to Sudan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Syrian Arab Republic (X%), while the prices for the other major destinations experienced more modest paces of growth.

Medicaments Containing Hormones Imports

Imports into Egypt

In 2022, supplies from abroad of medicaments containing hormones but not antibiotics decreased by X% to X tons, falling for the second consecutive year after two years of growth. Over the period under review, imports faced a deep slump. The most prominent rate of growth was recorded in 2019 when imports increased by X% against the previous year. Imports peaked at X tons in 2020; however, from 2021 to 2022, imports stood at a somewhat lower figure.

In value terms, medicaments containing hormones imports contracted rapidly to $X in 2022. Overall, imports showed a precipitous slump. The most prominent rate of growth was recorded in 2019 when imports increased by X%. Imports peaked at $X in 2020; however, from 2021 to 2022, imports failed to regain momentum.

Imports by Country

In 2022, the United States (X kg) constituted the largest supplier of medicaments containing hormones to Egypt, accounting for a approx. X% share of total imports.

From 2012 to 2022, the average annual rate of growth in terms of volume from the United States amounted to X%.

In value terms, the United States ($X) constituted the largest supplier of medicaments containing hormones but not antibiotics to Egypt.

From 2012 to 2022, the average annual rate of growth in terms of value from the United States amounted to X%.

Import Prices by Country

In 2022, the average medicaments containing hormones import price amounted to $X per ton, reducing by X% against the previous year. Over the period under review, the import price showed a precipitous decrease. The growth pace was the most rapid in 2020 an increase of X%. As a result, import price attained the peak level of $X per ton. From 2021 to 2022, the average import prices remained at a somewhat lower figure.

As there is only one major supplying country, the average price level is determined by prices for the United States.

From 2012 to 2022, the rate of growth in terms of prices for Canada amounted to X% per year.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :